Jim Cramer recently discussed Cencora, Inc. (NYSE:COR), an American pharmaceutical and healthcare services provider. The stock has gained 32.30% year-to-date, with raised profit per share guidance to $15.70-$15.95. Cramer expressed confidence in the stock, even stating he’d buy more if it dropped by 50%.

Cramer also highlighted peers like Cardinal Health and McKesson, noting their consistent strong performance. Despite recent challenges like potential Medicare pricing changes, Cencora and its counterparts have shown resilience and growth potential. Cramer emphasized the strength of these healthcare stocks in the market.

While Cencora, Inc. (NYSE:COR) shows promise as an investment, some believe other AI stocks offer greater potential. Investors seeking AI opportunities with low downside risk should explore a free report on the best short-term AI stock. This analysis emphasizes the potential of certain AI investments in the current market landscape.

Read more at Yahoo Finance: If It Was Down, I’d Say “Double Down And Buy,” Says Jim Cramer